Halberd (HALB) versus Its Rivals Critical Review
Halberd (OTCMKTS:HALB – Get Rating) is one of 361 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Halberd to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk. Institutional and Insider Ownership 26.0% of shares of all […]